Brief: Dyne Therapeutics Names Former Bioverativ Executive John Cox As New CEO

Dyne Therapeutics

25/03/2024 11:35

March 25 (Reuters) - Dyne Therapeutics Inc  DYN.O :
    * DYNE THERAPEUTICS ANNOUNCES CEO TRANSITION
    * DYNE THERAPEUTICS INC - JOHN COX, INDUSTRY LEADER WITH
GLOBAL
EXPERIENCE IN RARE DISEASE COMMERCIALIZATION, JOINS DYNE AS
PRESIDENT AND CEO 

Source text for Eikon:  ID:nGNX3KYFq1 
Further company coverage:  DYN.O 

 ((Reuters.Briefs@thomsonreuters.com;))